CAS: 359689-54-6 - (2S,5R)-5-[4-amino-2-oxo-3-(L-valyloxy)-3,6-dihydropyrimidin-1(2H)-yl]-3-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl dihydrochloride
Formel:C14H25Cl2N4O6
InChl:InChI=1/C14H23N4O6.2ClH/c1-7(2)12(16)13(21)24-18-10(15)3-4-17(14(18)22)11-5-8(20)9(6-19)23-11;;/h3,7,9,11-12,19-20H,4-6,15-16H2,1-2H3;2*1H/t9-,11+,12-;;/m0../s1
Marke | Produktdaten | Reinheit | Preisklasse | Voraussichtliche Lieferung |
---|---|---|---|---|
2'-Deoxy-L-cytidine 3'-O-L-valinyl ester 2HCl REF: 3D-ND10527CAS: 359689-54-6 | Min. 95% | 180,00 €~714,00 € | Mo 25 Nov 24 | |
Valtorcitabine dihydrochloride REF: TM-T29095CAS: 359689-54-6 | - - - | 1.660,00 €~2.826,00 € | Do 16 Jan 25 |
2'-Deoxy-L-cytidine 3'-O-L-valinyl ester 2HCl
CAS:359689-54-6
2'-Deoxy-L-cytidine 3'-O-L-valinyl ester 2HCl is a nucleoside analog that is converted to its active form …
Formel:
C14H22N4O5·2HCl
Reinheit:
Min. 95%
Farbe und Form:
Off-White Powder
Molekulargewicht:
399.27 g/mol
Ref: 3D-ND10527
1mg | 180,00 € | ||
2mg | 238,00 € | ||
5mg | 356,00 € | ||
10mg | 452,00 € | ||
25mg | 714,00 € |
Voraussichtliche Lieferung in Vereinigte Staaten, am Montag 25. November 2024
Valtorcitabine dihydrochloride
CAS:359689-54-6
Valtorcitabine dihydrochloride, a DNA polymerase inhibitor, is used potentially for the treatment of HBV infection.
Formel:
C14H24Cl2N4O5
Farbe und Form:
Solid
Molekulargewicht:
399.27
Ref: TM-T29095
25mg | 1.660,00 € | ||
50mg | 2.170,00 € | ||
100mg | 2.826,00 € |
Voraussichtliche Lieferung in Vereinigte Staaten, am Donnerstag 16. Januar 2025